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Introduction
Traditionally phamacists in Australia have practiced in 
the hospital or community pharmacy setting. The integra-
tion of pharmacists in general practice is an example of 
an inter-professional collaborative intervention that has 
previously been demonstrated to improve both health 
and economic outcomes [1, 2]. This emerging area of pro-
fessional practice provides a novel opportunity for phar-
macists to demonstrate their cognitive pharmacotherapy 
skills and utilise team-based care. The proposed role of the 
general practice pharmacist includes not only providing 
direct medication management services to patients but 
may also include review of general practice prescribing 
and disease state management [3]. 
Previous studies [4–6] have identified factors that 
can affect the implementation of inter-professional 
interventions involving general practice pharmacists 
including the importance of pharmacists being co-located 
with the general practice team, pharmacists demonstrat-
ing positive characteristics including adaptability and 
proactivity and pharmacists ensuring that they avoid neg-
atively viewed roles such as diagnosing and dispensing.
There have been limited studies describing the com-
ponents of interventions used by pharmacists integrated 
in general practice [7, 8]. These studies did not evaluate 
or compare different aspects of the intervention compo-
nents and there is subsequently no established best prac-
tice model for the integration of pharmacists in general 
practice. 
In response to this evidence, and also to a perceived 
need for patient centred collaborative care, a Primary 
Health Network (administrative health region) in Western 
Sydney NSW, WentWest, has commissioned a project 
involving the integration of five pharmacists across twelve 
general practice sites with the pilot phase of the project 
beginning in March 2016. The target population of the 
project was patients at risk of medication misadventure 
with a focus on patients with complex medication regi-
mens and/or multiple co-morbidities. 
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Healthcare interventions involving inter-professional 
collaboration are complex interventions. This is due to the 
involvement of multiple professional groups, the fact that 
the interventions involve many interacting components 
and also because they pose numerous implementation 
challenges. A systematic review by Supper et al. [9] dem-
onstrated that inter-professional collaborative interven-
tions have previously been associated with improvements 
in patient care across multiple contexts and professions. 
In contrast, a further systematic review by Schepman et al. 
[10] examined the common characteristics and outcomes 
of inter-professional collaborative interventions in pri-
mary health care and found that not all interventions were 
associated with positive health or economic outcomes. 
Traditionally the evaluation of complex interventions 
has relied on reviewing study outcomes. This approach may 
lead to overlooking important implementation  elements 
that may have contributed to how, or why, an intervention 
was successful and the influence of  situational context on 
the intervention. More recently the use of process evalua-
tion is being increasingly recognised as a valid technique 
for analysing complex interventions [12, 13]. Conducting 
a process evaluation in an intervention’s pilot phase may 
help to identify potential issues and allow the adjustment 
of the interventional design to avoid future intervention 
outcome failure.
According to the Medical Research Council guidance, 
a process evaluation combines qualitative and quantita-
tive methods to provide valuable insights into complex 
interventions. This is achieved by investigating (1) the 
mechanisms of impact used to achieve the intervention 
outcomes (2) the circumstances affecting how an inter-
vention was implemented, and (3) how the situational 
context of the intervention affected its implementation 
and potential reproducibility [11]. This analysis provides 
important insight on the feasibility, appropriateness and 
acceptability of the intervention. These insights can then 
be used to assist future implementation planning and to 
improve reliability and reproducibility of outcomes by 
considering situational context and its impact. 
When analysing the implementation of healthcare 
interventions, the Tailored Implementation for Chronic 
Diseases (TICD) checklist provides a framework for clas-
sifying barriers and facilitators to implementation. This 
checklist includes seven domains of factors affecting 
implementation. These include guideline factors, indi-
vidual health professional factors, patient factors, profes-
sional interactions, incentives and resources, capacity for 
organisational change and social, political and legal fac-
tors [14].
The aim of this study was to conduct a preliminary pro-
cess evaluation to inform the adaptation of the integrated 
pharmacist intervention. 
Description of care practice
Methods
A mixed methods study was conducted to evaluate the pro-
cess of integrating pharmacists in the Australian  general 
practice setting, using a combination of semi-structured 
interviews with pharmacists and general practitioners 
(i.e., qualitative data) and an ad-hoc dataset created for the 
delivery of the project (i.e., quantitative data).
Qualitative data was collected using one-on-one semi-
structured interviews conducted either by telephone or 
face to face. All five pharmacists and a convenience sam-
ple of general practitioners selected by WentWest were 
approached by the WentWest head office and asked to 
participate in an interview with a member of the UTS 
research team between May and July 2016. Participants 
who consented to be interviewed were then contacted by 
the UTS researcher to arrange the interview. According to 
the Medical Research Council (UK) framework for con-
ducting process evaluations [1] interview questions were 
designed to elicit information to:
(1) describe the interventional model used and its 
application in practice. 
(2) inform about circumstances that may have 
affected the implementation of the intervention; 
and,
(3) understand the situational context of the prac-
tice site.
Table 1 details the interview questions and links these to 
the MRC (UK) themes.
As part of their usual practice, the pharmacists partici-
pating in the study collected quantitative patient data 
using a data collection spreadsheet (in Microsoft Excel 
2010©) that was developed to support the delivery of 
the intervention by the WentWest project team. This data 
was used to provide further insight into the three aspects 
encompassed by a process evaluation (Table 2).
Research ethics approval was obtained from the Human 
Research Ethics Committee at the University of Technology 
Sydney (ETH16-0689).
Data analysis: Qualitative data was analysed using frame-
work analysis. Data was coded according to the MRC-UK 
process evaluation key components of description of inter-
ventional model/mechanisms of impact, circumstances 
affecting implementation and situational context. This 
coding was reviewed by two researchers and a consensus 
on categorisation of the qualitative data was reached.
To describe processes relating to the interventional 
model the research team allocated the qualitative data 
to three different components reflecting the journey for 
patients with the integrated pharmacist service. These 
components allowed for modification and adjustment of 
data in the data analysis process. These categories were 
(i) patient selection and recruitment, (ii) the pharmacist 
consultation and (iii) communication and recording of the 
pharmacist recommendations.
To describe factors affecting implementation, elements 
that could hinder (i.e., barriers) or enable (i.e., facilita-
tors) the implementation of the service were identified 
(Table 3). The identified elements were distributed into 
five relevant domains identified using the comprehensive, 
integrated checklist of determinants of practice (TICD) 
developed by Flottorp et al. [14] including:
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a) guideline factors (information relating to clinical 
practice guideline characteristics, intervention 
characteristics, and innovation characteristics), 
b) individual health professional factors (information 
relating to knowledge, attributes and behavior of 
health practitioners), 
c) patient factors (information relating to patient 
barriers, needs, experience, knowledge, skills, attitude 
and compliance), 
d) professional interactions (information relating 
to healthcare inter-professional barriers, network 
communications and culture, system characteristics 
and environmental and social factors including 
social influences and context), and 
e) incentives and resources (information relating to 
financial support, resources and incentives).
Two domains from the original checklist by Flottorp et al. 
[14] were excluded after data analysis due to a lack of rel-
evant data for evaluation of the domains these were: 
f) capacity for organisational change and 
g) social, political and legal factors.
Finally data relating to contextual factors and processes 
shaping how the intervention works were allocated to 
situational context.
Quantitative data collected from the pharmacists 
was then entered into the Statistical Package for Social 
Sciences (SPSS) for Windows Version 24.0 (IBM, New York, 
USA.) for analysis of descriptive statistics [15]. Means and 
standard deviations were calculated to summarise quanti-
tative variables where relevant. 
Results
Qualititative data was collected from four pharmacists as 
one pharmacist had left the project.
Five of twenty participating general practitioners agreed 
to be interviewed. These general practitioners came from 
four separate practice sites.
(1) Adaptation of interventional model by project 
practices. 
Figure 1 depicts a summary of findings relating to the 
interventional model design adapted by each practice and 
includes three components:
i) Patient Selection and recruitment. 
 Patients were targeted for recruitment if they were 
taking more than five medications, were suspected of 
having an adverse reaction or medication adherence 
issues or required chronic disease management.
Both pharmacists (n = 3) and general practitioners 
(n = 2) mentioned that the recruitment process 
worked best when the patients were identified by 
and booked in by the pharmacist. The reasons for this 
included that the pharmacist was motivated to recruit 
patients in contrast with other practice staff who saw 
this task as burdensome, that the pharmacist was 
most able to clearly articulate their role and identify 
potential benefits of the service for the patient and 
Table 1: Semi-structured interview questions.
Questions to pharmacists (MRC-UK themes)
•  Please outline the process used to identify and book patients to see the clinical pharmacist at the surgeries you service.
(Description of Interventional Model)
• Does the process differ between patients or surgeries? (If so, please describe how.)
• What is the procedure you use when conducting patient consultations? (Description of Interventional Model)
•  Does this procedure vary for different medical conditions or different surgeries? (If so, please describe how.) (Situational 
Context)
How are the results of the consultation recorded? (Description of Interventional Model)
Please outline the procedure used for communicating the results of the patient/pharmacist consultation to the general 
practitioner: (Description of Interventional Model)
• Does this procedure differ at different surgeries? (If so, please describe how.) (Situational Context)
What barriers have you experienced that reduced your effectiveness in integrating with the practice? (Circumstances affect-
ing implementation) What facilitators have you observed that have assisted your integration into the practice? (Circumstances 
 affecting implementation). 
Questions to general practitioners
•  What are your overall impressions of the clinical pharmacist project? (Circumstances affecting implementation, 
 Situational context)What activities would you like the clinical pharmacists to perform during their time at the surgery? 
(Description of Interventional Model)
•  What is the preferred method for the clinical pharmacist to communicate their recommendations to you? (Description of 
Interventional Model)
What barriers have your observed that may reduce the effectiveness of the project? (Circumstances affecting imple-
mentation)What issues do you think may reduce the ability of the clinical pharmacist to improve patient outcomes? 
(Circumstances affecting implementation)What facilitators have you observed related to the project? (Circumstances 
affecting implementation) What can you suggest that may improve the effectiveness of the clinical pharmacist project? 
(Circumstances affecting implementation)
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Table 3: Consultation data March–June 2016 (n = 299 consultations).
Demographics Average patient age (years) 69.5 ±12.1
Average number of patient co-morbidities 7.1 ± 2.4
Average number of medications per patient 
(prescription and non-prescription)
9.6 ± 4.0
Pharmacist recommendations Total number 807
Number recorded as accepted 329*
Medication dose reduction 147
Medication Cessation 173
Medication dose increase 47
New medication added 85
Suspected adverse drug reaction 85
Potential drug interaction 78
Other recommendations 192
Other actions Detection and resolution of discrepancies in 
patient record
349
* Pharmacist 2 did not record the number of recommendations accepted.
Table 2: Quantitative data fields used to inform the process evaluation.
Variable* Process Evaluation 
Theme(s)
Description
Number of current medicines (prescription and 
non- prescription)
Interventional Model These variables were used to provide informa-
tion on patient demographics to allow evaluation 
of the selection and recruitment process and to 
establish if the recruited patients reflected the 
project target population.
Number of current comorbidities Interventional Model
Age Interventional Model
Number of medication cessation 
recommendations
Interventional Model These variables informed the researchers of the 
activities conducted during the patient consulta-
tion and provided insight into the impact of the 
intervention.
Number of addition of new medication  
recommendations
Interventional Model
Number of recommendations for dose reduction Interventional Model
Number of suspected ADR identified Interventional Model
Number of suspected drug interactions detected Interventional Model
Number of recommendations for dose increase Interventional Model
Number of recommendations actioned by GP Circumstances affecting 
implementation
Situational Context
This variable provided insight into the effective-
ness of the intervention and the level of collabo-
ration between different practitioners. It was also 
used to demonstrate the differences in acceptance 
of the intervention at different sites to inform the 
situational context.
Number of recommendations by pharmacist Circumstances affecting 
implementation
Situational Context
This variable provided information on the ability 
of the pharmacist to implement the intervention.
Differences in this variable were used to demon-
strate the differences between pharmacist practi-
tioners in conducting the intervention.
Practice ID Situational Context This variable allowed the researchers to consider 
the data from different practice sites to inform 
the situational context.
Pharmacist ID Situational Context This variable allowed the researchers to identify 
different pharmacist practitioners to inform the 
situational context.
* This table describes selected variables that were used to inform the process evaluation and is not a comprehensive list of the 
 variables collected.
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that the pharmacist was easily able to identify patients 
who would most benefit from the service.
ii) Pharmacist consultation.
 A total of 12 actions were undertaken as part of 
the patient consultation (Figure 1). All pharmacists 
performed medication review, medication reconciliation 
and a review of relevant lab results. Three of the four 
pharmacists conducted general practitioner education, 
chronic disease management, clinical assessment and 
organised follow up. Only one of the four pharmacists 
conducted group education, support groups and 
participated in patient telephone consultations.
This data provided evidence for the role of the pharmacist 
in conducting medication reconciliation and review and 
the identification of medication related problems as part 
of the patient consultation process.
iii) Communication and recording of recommendations.
All pharmacists had access to patient records and were 
able to document their recommendations in the patient 
record. Qualitative data collected in response to interview 
questions relating to communication of recommenda-
tions indicated that all pharmacists and general practi-
tioners agreed that having a face to face interview was 
best. Ideally this would be a three way interview with the 
patient, pharmacist and general practitioner to agree on 
an action plan relating to the pharmacist’s recommenda-
tions. This was not always the practice implemented due 
to a lack of general practitioner availability. 
Quantitative data from project pharmacists indicated 
that the process of recording consultation data was not 
consistent between pharmacists. Considerable variation 
in recording processes existed, for example, three of the 
Figure 1: Intervention Model Design/Mechanisms of Impact.
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five pharmacists included detailed descriptions of the 
recommendations made to general practitioners but two 
only recorded the number of recommendations made in 
each category without recording detail on agents involved.
Factors affecting implementation of the general prac-
titioner-pharmacist intervention are outlined in Table 4.
Implementation Factors
(a) Guideline factors
The data collection sheet designed by the project team 
was not comprehensive. For example, the data collection 
sheet did not include a field for the date of the consul-
tation, the site of the consultation (relevant when they 
were visiting multiple sites) or the patient’s general prac-
titioner. An additional limitation to the data collection 
method was that when a patient was seen more than once 
the data from all visits was recorded in the same line of 
the spreadsheet so it was not possible to determine which 
recommendations corresponded to which visit.
(b) Individual health professional factors
Both pharmacists and general practitioners stated that 
the intervention works best when general practitioners 
are enthusiastic and willing to collaborate. General practi-
tioners who actively recommended the pharmacist to the 
patient were seen as facilitators by several pharmacists 
and general practitioners. Several general practitioners 
mentioned that they thought the pharmacist should be 
both clinically competent and pro-active, and effective 
communication skills were identified as a facilitator. 
At some sites despite participating in the project a lack 
of general practitioner co-operation from individual prac-
titioners was seen as a barrier.
In addition uncertainty from practice staff, general prac-
titioners and patients regarding the role of the pharmacist 
was felt to reduce the effectiveness of the intervention.
One general practitioner felt that they viewed the prac-
tice pharmacist as a threat to the general  practitioner’s pro-
fessional territory and was worried about the  pharmacist’s 
activities eroding their role. GP1 “I think GPs assume that 
this is the start of a slippery slope where pharmacists will 
try to expand their role and encroach on the GPs territory.”
(c) Patient Factors
The majority of pharmacists and one general practitioner 
stated that they had observed patient resistance to the 
service and that this was suggested to be a barrier to both 
recruitment of patients and the effectiveness of the inter-
vention. In addition two pharmacists stated that they had 
difficulty recruiting patients to the service. Two general 
Table 4: TICD implementation factors.
TICD Domain Barrier Facilitator
Guideline factors Lack of guidelines, training and resources.
Uncertain project timelines.
Data collection spreadsheet design.
Individual health 
professional factors
Individual general practitioners resistant to 
service.
Individual pharmacist characteristics- lack of 
confidence and/or competence.
Pharmacist perceived as a threat to the 
 general practitioner’s professional territory.
General practitioners willing to collaborate.
Positive professional relationship between pharmacist and 
general practitioner.
Warm handover.
Pharmacist proactive and clinically competent.
Good communication between pharmacist and general 
practitioner.
Patient Factors Patient resistance to service. Improvement in patient outcomes due to ongoing follow 
up and review.
Improved communication due to real time synchronous 
discussion.
Doctor recommendation and introduction of the 
 pharmacist reduced patient resistance
Professional  
Interactions
Lack of an established relationship between 
pharmacist and general practitioner and/or 
practice staff.
Lack of general practitioner co-operation.
Uncertainty regarding the role of the practice 
pharmacist. 
Resistance from community pharmacy. 






Costs relating to the intervention. 
Lack of pharmacist remuneration and 
 government funding for the service.
Limited availability of the clinical pharmacist.
Allocation of sufficient funding.
Increased pharmacist contact hours.
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practitioners stated that ongoing contact with a pharmacist 
overcomes patient resistance to the service and improves 
outcomes. GP4 “Patients respond well to the accredited 
pharmacists manner.”
(d) Professional Interactions
In the semi-structured interviews the lack of an estab-
lished relationship between the individual pharmacist, 
general practitioner and the practice staff was raised as an 
initial barrier by all pharmacists and general practitioners. 
For example, Pharmacist 3 stated “I had no previous rela-
tionship with either of the GP’s and it took several weeks 
of consultations to establish my credibility.”
Several of the general practitioners communicated 
that they thought that their local community pharma-
cies would find the presence of the practice pharmacist 
threatening and were concerned about the impact of the 
intervention on their existing collaborative relationships 
with community pharmacy. 
Both general practitioners and pharmacists indicated 
that support from the other members of the practice team 
improved the success of the intervention. 
(e) Incentives and resources
Costs relating to the intervention included the cost of the 
consultation room, software login and surgery utilities. 
One pharmacist mentioned that they had been employed 
for several weeks without receiving payment and that 
without reliable wages they were unlikely to continue 
working for the project.GP5 “The lack of grant money and 
ability to pay the pharmacist’s ongoing salary is a barrier 
to the service.”
The clinical pharmacists were often only present at 
practice sites for between four and eight hours per week. 
This limited availability was raised as a barrier to  effective 
implementation of the service as the limited contact 
hours was seen to reduce the practice pharmacists’ poten-
tial impact. One pharmacist and two general  practitioners 
mentioned that increasing the pharmacist contact hours 
increases collaboration and the effectiveness of the 
intervention.
Situational context
There was no agreed protocol for the intervention across 
the project. As a result the method of patient selection and 
recruitment, the activities conducted by each practitioner 
and the way the results of the consultation were recorded 
and communicated varied between both practitioners and 
practice sites. One example is that four different methods 
were used for the selection and recruitment of patients.
The level of support for pharmacists provided by prac-
tices varied between sites. This included aspects of physi-
cal design (lack of a room, nameplate), the provision of 
support from other practice staff and provision of access 
to information and systems. This is illustrated in the case 
of practice software access where most sites provided the 
pharmacist with an individual login for practice software 
but at one site one pharmacist relied on the reception 
staff to log them into the practice software.
Data collection procedures varied between pharma-
cists and not all pharmacists accurately recorded all data 
fields. For example, one pharmacist did not complete the 
co-morbidity field, or the percentage of recommenda-
tions accepted. In addition not all pharmacists recorded 
detail about the recommendations made as a result of the 
consultation which reduced the information provided for 
analysis regarding the activities performed.
Table 5 outlines quantitative information differences in 
different practice sites and between different pharmacist 
practitioners, highlighting the variability in both the aver-
age number of recommendations made by different phar-
macist practitioners and the differences in the percentage 
of recommendations accepted by general practitioners at 
various sites. The percentage of pharmacist recommenda-
tions accepted varied between practices as demonstrated 
by pharmacist four who had a 75% acceptance rate at one 
surgery and a 67% acceptance rate at the second surgery.
Discussion
This study provides key information about how a newly 
implemented integrated healthcare intervention works in 
a real-world setting. By examining the mechanisms used 
to achieve the intervention outcomes, the circumstances 
affecting how the intervention was implemented, and 
how the situational context of the intervention affected 
its implementation, insights were gained to enable sug-
gestions for improvement in processes for the project 
going forward. The lack of a standardised intervention pro-
cedure allowed comparison of the different approaches 
used between both pharmacists and different practice 
sites and this in turn increased the potential learnings 
available from the process evaluation. 
Table 5: Quantitative data informing the Situational context.
Pharmacist Number of recommendations made per  
patient consultation
(mean ± standard deviation)
Recommendations accepted  
by general practitioner n (%)
1 2.6 ± 2.0 97 (94) 
2 2.2 ± 1.8 Not evaluable*
3 3.6 ± 1.4 39 (91)
4 4.3 ± 1.4 121 (72)
5 3.7 ± 1.6 72 (92)
* Pharmacist 2 did not consistently record the number of recommendations accepted by the GP.
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In a systematic review of inter-professional collaborative 
interventions Supper et al. [9] found that a flexible model 
of care that was adapted for the setting and stakeholders 
received greater support from the team. The model of col-
laborative care used in the WentWest project appeared to 
support this premise as, although there were some com-
mon activities at each site, many of the processes and pro-
cedures conducted by the pharmacists varied depending 
on the requirements of each practice and the health care 
professionals and patients involved.
The professional relationship between the GP, health 
professional and practice staff are identified as a key 
implementation consideration in previous studies [4–6] 
and this was supported by our study. Establishing the pro-
fessional credibility of the health professional (in this case 
the pharmacist) and clearly describing their role to all col-
laborators may help to proactively assist the development 
of a collaborative professional relationship. Funding and 
system level support is essential in allowing not only suc-
cessful initial implementation of an intervention but also 
for the longer term exploration and maintenance stages. 
Supper et al. [9] identified the lack of remuneration, long-
term funding and physical space as a significant barrier for 
pharmacists. These findings are supported by the results 
of this evaluation in which several participants identified 
both the lack of government funding and the difficulty of 
allocating consultation space for the pharmacists as signif-
icant barriers to the provision of the integrated pharma-
cist service. Long term sustainability of the intervention 
relies on sufficient ongoing funding and any implementa-
tion plan should include a comprehensive funding model.
Previous studies examining roles and guidelines for 
pharmacists integrated in primary care teams have identi-
fied the importance of establishing the role of the phar-
macist in accordance with the needs and priorities of 
the general practice team and patients. In addition, the 
importance of ensuring that pharmacists are clinically 
competent, highly visible and proactive was identified 
as requirement for successful integration [16, 17]. These 
findings were supported by the process evaluation results 
where project pharmacists found patient recruitment and 
communication of recommendations to general practi-
tioners worked best where the pharmacist role and pro-
fessional competencies were clearly understood.
Differences in situational context including individual 
practitioner pharmacist characteristics and differences in 
setting were both found to be important in predicting the 
success of a pharmacist’s integration and effectiveness by 
Jorgensen et al. [6] who examined the differences in the 
success of inter-professional collaboration between 24 
pharmacists integrated into primary care teams in Canada. 
In the WentWest project several differences were identi-
fied in both the qualitative and quantitative data between 
individual practitioner pharmacists and between differ-
ent practice sites. Sometimes these differences were due 
to different procedures adopted by different practition-
ers illustrated by the differences in data recording proce-
dures and in other instances the cause of the variation was 
more difficult to detect. Ensuring that pharmacists receive 
training in essential project procedures such as data col-
lection and recording prior to the commencement of the 
project should increase the level of consistency of results 
between practitioners. Other contextual differences such 
as the ability of a pharmacist to proactively communicate 
and overcome barriers to collaboration are perhaps more 
difficult to address but should still be taken into account 
when planning an intervention.
This study highlights the importance of clearly defin-
ing and communicating an intervention’s components 
to all collaborators. In addition, ensuring that all staff 
are trained and provided with sufficient guidelines, 
resources and system level support will improve the con-
sistency and reproducibility of an intervention’s  delivery. 
Establishing health practitioner competency and cred-
ibility and clearly defining individual  practitioner roles 
will assist with improving the effectiveness of a col-
laborative intervention. In addition, effective inter-pro-
fessional communication between all collaborators will 
improve the success of complex interventions involving 
multiple health practitioners.
This study was limited by the time and resources avail-
able to the research team. As a result the sample size of 
general practitioners interviewed was limited to five out 
of a potential 20 general practitioners and this may have 
meant that data saturation was not reached and there are 
further potential learnings that have not been presented 
in the data. However, the information gathered from the 
interviews was sufficient to allow for the identification of 
the main themes. It recommended that further process 
evaluation is conducted at later stages of the project to 
ensure that the learnings from the study are comprehen-
sive and allow for further adjustment of the model and 
implementation plan where required.
This process evaluation has provided insight into the 
potential impact of pharmacists in general practice. 
Additional research is required, and currently underway 
examining the economic, humanistic and clinical out-
comes resulting from the integration of general practice 
pharmacists.
Conclusion
Conducting a process evaluation in the pilot phase of a 
complex intervention is particularly relevant as it ena-
bles the intervention model to be adapted to reduce the 
chance of future intervention failure. Addressing rele-
vant implementation barriers and facilitators, evaluating 
intervention model design and considering situational 
context can aid the development of a robust, reproduc-
ible intervention that is potentially less likely to fail in 
the exploration and sustainability phase. The analysis of 
both qualitative and quantitative data collected in the first 
twelve weeks of the WentWest non-dispensing pharmacist 
project by the UTS research team has allowed the authors 
to provide advice and insight to the project team and 
has resulted in the standardisation of the interventional 
model.
The results from this process evaluation were communi-
cated to WentWest via an internal report and the UTS team 
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assisted in implementing the report recommendations by 
liaising with the WentWest project team and by conduct-
ing a training day for all participating project pharmacists. 
As a result of this study adjustments have been made to 
the ongoing project including changes to patient selec-
tion and recruitment procedures, Activities conducted 
during the patient consultation and communication and 
recording of pharmacist recommendations.
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